136 related articles for article (PubMed ID: 30506121)
1. L-type calcium channel blockers and a symptom complex mimicking de Melo-Souza's syndrome.
Kaur U; Das P; Gambhir IS; Chakrabarti SS
Neurol Sci; 2019 May; 40(5):1077-1080. PubMed ID: 30506121
[No Abstract] [Full Text] [Related]
2. Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain. Gastrointestinal Therapeutic System.
Testa MA; Turner RR; Simonson DC; Krafcik MB; Calvo C; Luque-Otero M
J Hypertens; 1998 Dec; 16(12 Pt 1):1839-47. PubMed ID: 9869019
[TBL] [Abstract][Full Text] [Related]
3. Flunarizine and cinnarizine-induced parkinsonism: 25 years of de Melo-Souza's syndrome.
Teive HA; Munhoz RP; Ferraz HB
Arq Neuropsiquiatr; 2009 Sep; 67(3B):957. PubMed ID: 19838540
[No Abstract] [Full Text] [Related]
4. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
[TBL] [Abstract][Full Text] [Related]
5. [Gingival hyperplasia induced by amlodipine].
Salerno L; Pepe S; Gullotti D; Iacò V
Clin Ter; 1995 Apr; 146(4):275-8. PubMed ID: 7796559
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
[TBL] [Abstract][Full Text] [Related]
7. Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.
Massie BM; Lacourcière Y; Viskoper R; Woittiez A; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):27C-33C. PubMed ID: 9286851
[TBL] [Abstract][Full Text] [Related]
8. Using administrative data to compare the relative effectiveness of amlodipine vs nifedipine CC.
Lenert LA; Linde-Zwirble W; Newbold R; Korenblat BM; Doherty J; Smith ME
Am J Manag Care; 1999 Dec; 5(12):1535-40. PubMed ID: 11066620
[TBL] [Abstract][Full Text] [Related]
9. Effects of benidipine in a rat model for experimental angina.
Ikeda J; Matsubara M; Yao K
Yakugaku Zasshi; 2006 Dec; 126(12):1377-81. PubMed ID: 17139163
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety of nifedipine coat-core versus amlodipine in the treatment of patients with mild-to-moderate essential hypertension. Hypertension Study Group.
Zidek W; Spiecker C; Knaup G; Steindl L; Breuer HW
Clin Ther; 1995; 17(4):686-700. PubMed ID: 8565032
[TBL] [Abstract][Full Text] [Related]
11. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release.
Mounier-Vehier C; Bernaud C; Carré A; Lequeuche B; Hotton JM; Charpentier JC
Am J Hypertens; 1998 Apr; 11(4 Pt 1):478-86. PubMed ID: 9607387
[TBL] [Abstract][Full Text] [Related]
12. Differential effects on out-of-hospital cardiac arrest of dihydropyridines: real-world data from population-based cohorts across two European countries.
Eroglu TE; Mohr GH; Blom MT; Verkerk AO; Souverein PC; Torp-Pedersen C; Folke F; Wissenberg M; van den Brink L; Davis RP; de Boer A; Gislason GH; Tan HL
Eur Heart J Cardiovasc Pharmacother; 2020 Nov; 6(6):347-355. PubMed ID: 31504369
[TBL] [Abstract][Full Text] [Related]
13. Use of calcium-channel blockers in pediatric renal transplant recipients.
Silverstein DM; Palmer J; Baluarte HJ; Brass C; Conley SB; Polinsky MS
Pediatr Transplant; 1999 Nov; 3(4):288-92. PubMed ID: 10562973
[TBL] [Abstract][Full Text] [Related]
14. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A
Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study.
Ellis JS; Seymour RA; Steele JG; Robertson P; Butler TJ; Thomason JM
J Periodontol; 1999 Jan; 70(1):63-7. PubMed ID: 10052772
[TBL] [Abstract][Full Text] [Related]
16. Amlodipine treatment of cocaine dependence.
Malcolm R; Brady KT; Moore J; Kajdasz D
J Psychoactive Drugs; 1999; 31(2):117-20. PubMed ID: 10437993
[TBL] [Abstract][Full Text] [Related]
17. Tremor and Parkinson's disease.
Boddie H
Practitioner; 1989 Aug; 233(1473):1101-2. PubMed ID: 2602338
[TBL] [Abstract][Full Text] [Related]
18. [Amlodipin (Norvasc). A new calcium antagonist with long half-life].
Thaulow E; Erikssen J; Lund-Johansen P
Tidsskr Nor Laegeforen; 1991 Jun; 111(16):1981-2. PubMed ID: 1830978
[No Abstract] [Full Text] [Related]
19. Calcium channel blockers and benign hypertension.
Gurm HS; Farooq M
Arch Intern Med; 1999 May; 159(9):1011. PubMed ID: 10326948
[No Abstract] [Full Text] [Related]
20. Nifedipine and other calcium channel blockers.
Pahor M
Eur Heart J; 1997 Jan; 18(1):168. PubMed ID: 9049532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
